Synovial mesenchymal stem cells for knee cartilage injury

doi:10.3969/j.issn.2095-4344.2015.36.026

Abstract

Abstract:

BACKGROUND: Knee cartilage injury is difficult to heal, which is an urgent clinical problem to solve.

OBJECTIVE: To summarize the advantages of synovial mesenchymal stem cells in the treatment of knee cartilage injury.

METHODS: A computer-based search of PubMed was performed for articles related to synovial mesenchymal stem cells for knee cartilage injury using the keywords of “knee joint, cartilage, synovial membrane, tissues, injuries and repair”. A total of 48 articles were retrieved initially, and 35 articles were included in result analysis.

RESULTS AND CONCLUSION: Synovial mesenchymal stem cells for treatment of knee cartilage injury can achieve more ideal outcomes. Mesenchymal stem cells inherent in the damaged tissue are the optimal seed cells for tissue repair.

中国组织工程研究杂志出版内容重点：干细胞；骨髓干细胞；造血干细胞；脂肪干细胞；肿瘤干细胞；胚胎干细胞；脐带脐血干细胞；干细胞诱导；干细胞分化；组织工程

Key words: Knee Joint, Synovial Membrane, Mesenchymal Stem Cells

CLC Number:

R318

Chen Qi, Liao Wen-bo. Synovial mesenchymal stem cells for knee cartilage injury [J]. Chinese Journal of Tissue Engineering Research, 2015, 19(36): 5886-5891.

Figures/Tables 1

References

[1] Ong E, Chimutengwende-Gordon M, Khan W. Stem cell therapy for knee ligament, articular cartilage and meniscal injuries. Curr Stem Cell Res Ther. 2013;8(6):422-428.

[2] Rodriguez-Merchan EC. Regeneration of articular cartilage of the knee. Rheumatol Int. 2013;33(4):837-845.

[3] Bert JM. Abandoning microfracture of the knee: has the time come. Arthroscopy. 2015;31(3):501-505.

[4] Lubowitz JH. Arthroscopic microfracture may not be superior to arthroscopic debridement, but abrasion arthroplasty results are good, although not great. Arthroscopy. 2015;31(3):506.

[5] Oussedik S, Tsitskaris K, Parker D. Treatment of articular cartilage lesions of the knee by microfracture or autologous chondrocyte implantation: a systematic review. Arthroscopy. 2015;31(4):732-744.

[6] Erickson IE, Kestle SR, Zellars KH, et al. Improved cartilage repair via in vitro pre-maturation of MSC-seeded hyaluronic acid hydrogels. Biomed Mater. 2012;7(2):024110.

[7] Iwakura T, Sakata R, Reddi AH. Induction of chondrogenesis and expression of superficial zone protein in synovial explants with TGF-β1 and BMP-7. Tissue Eng Part A. 2013;19(23-24): 2638-2644.

[8] Yoshimura H, Muneta T, Nimura A, et al. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res. 2007;327(3):449-462.

[9] Sakaguchi Y, Sekiya I, Yagishita K, et al. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005;52(8):2521-2529.

[10] Shirasawa S, Sekiya I, Sakaguchi Y, et al. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: optimal condition and comparison with bone marrow-derived cells. J Cell Biochem. 2006;97(1):84-97.

[11] Yu H, Adesida AB, Jomha NM. Meniscus repair using mesenchymal stem cells - a comprehensive review. Stem Cell Res Ther. 2015;6:86.

[12] Campbell DD, Pei M. Surface markers for chondrogenic determination: a highlight of synovium-derived stem cells. Cells. 2012;1(4):1107-1120.

[13] Zhang Z, Ding Y, Li W, et al. Interleukin-17A- or tumor necrosis factor α-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis. Arthritis Res Ther. 2013;15(5):R169.

[14] Jones BA, Pei M. Synovium-derived stem cells: a tissue-specific stem cell for cartilage engineering and regeneration. Tissue Eng Part B Rev. 2012;18(4):301-311.

[15] Caldwell KL, Wang J. Cell-based articular cartilage repair: the link between development and regeneration. Osteoarthritis Cartilage. 2015;23(3):351-362.

[16] Shao Z, Zhang X, Pi Y, et al. Surface modification on polycaprolactone electrospun mesh and human decalcified bone scaffold with synovium-derived mesenchymal stem cells-affinity peptide for tissue engineering. J Biomed Mater Res A. 2015;103(1):318-329.

[17] Fan J, Varshney RR, Ren L, et al. Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng Part B Rev. 2009; 15(1):75-86.

[18] Bianco P, Cao X, Frenette PS, et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med. 2013;19(1):35-42.

[19] Li Z, Liao W, Zhao Q, et al. Angiogenesis and bone regeneration by allogeneic mesenchymal stem cell intravenous transplantation in rabbit model of avascular necrotic femoral head. J Surg Res. 2013;183(1):193-203.

[20] Gómez-Barrena E, Rosset P, Lozano D, et al. Bone fracture healing: cell therapy in delayed unions and nonunions. Bone. 2015;70:93-101.

[21] Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.

[22] Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007;262(5): 509-525.

[23] Ogata Y, Mabuchi Y, Yoshida M, et al. Purified Human Synovium Mesenchymal Stem Cells as a Good Resource for Cartilage Regeneration. PLoS One. 2015;10(6):e0129096.

[24] Pei M, He F, Vunjak-Novakovic G. Synovium-derived stem cell-based chondrogenesis. Differentiation. 2008;76(10): 1044-1056.

[25] Dry H, Jorgenson K, Ando W, et al. Effect of calcium on the proliferation kinetics of synovium-derived mesenchymal stromal cells. Cytotherapy. 2013;15(7):805-819.

[26] Lee DH, Joo SD, Han SB, et al. Isolation and expansion of synovial CD34(-)CD44(+)CD90(+) mesenchymal stem cells: comparison of an enzymatic method and a direct explant technique. Connect Tissue Res. 2011;52(3):226-234.

[27] Li J, Hansen KC, Zhang Y,et al. Rejuvenation of chondrogenic potential in a young stem cell microenvironment. Biomaterials. 2014;35(2):642-653.

[28] Tateishi K, Ando W, Higuchi C, et al. Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications. Cell Transplant. 2008;17(5):549-557.

[29] Ho CY, Sanghani A, Hua J, et al. Mesenchymal stem cells with increased stromal cell-derived factor 1 expression enhanced fracture healing. Tissue Eng Part A. 2015;21(3-4): 594-602.

[30] Kim YI, Ryu JS, Yeo JE, et al. Overexpression of TGF-β1 enhances chondrogenic differentiation and proliferation of human synovium-derived stem cells. Biochem Biophys Res Commun. 2014;450(4):1593-1599.

[31] Liu Y, Wang L, Kikuiri T, et al. Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nat Med. 2011;17(12):1594-1601.

[32] Hagmann S, Gotterbarm T, Müller T, et al. The influence of bone marrow- and synovium-derived mesenchymal stromal cells from osteoarthritis patients on regulatory T cells in co-culture. Clin Exp Immunol. 2013;173(3):454-462.

[33] Li A, Xia X, Yeh J, et al. PDGF-AA promotes osteogenic differentiation and migration of mesenchymal stem cell by down-regulating PDGFRα and derepressing BMP-Smad1/5/8 signaling. PLoS One. 2014;9(12):e113785.

[34] Longo UG, Loppini M, Forriol F,et al. Advances in meniscal tissue engineering. Stem Cells Int. 2012;2012:420346.

[35] Shintani N, Hunziker EB. Chondrogenic differentiation of bovine synovium: bone morphogenetic proteins 2 and 7 and transforming growth factor beta1 induce the formation of different types of cartilaginous tissue. Arthritis Rheum. 2007; 56(6):1869-1879.